Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity

Journal of Experimental Medicine

Volumn 183, Issue 1, 1996, Pages 283-287

  Celluzzi, Christina M ^a   Mayordomo, Jose I ^a   Storkus, Walter J ^a   Lotze, Michael T ^a   Falo Jr , Louis D ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CANCER IMMUNOLOGY; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY TEST; DENDRITIC CELL; FEMALE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; CYTOTOXICITY, IMMUNOLOGIC; DENDRITIC CELLS; FEMALE; IMMUNIZATION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NEOPLASMS, EXPERIMENTAL; PEPTIDE FRAGMENTS; SURVIVAL ANALYSIS; THYMOMA;

EID: 0030048724     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.1.283     Document Type: Article

References (44)

1. Doherty, P.C., B.B. Knowles, and P.J. Wettstein 1984. Immunological surveillance of tumors in the context of major histocompatibility restriction of T-cell function. Adv. Cancer Res. 42:1-65.
2. Rosenberg, S.A., B.S. Packard, P.M. Aebersold, D. Solomon, S.L. Topalian, S.T. Toy, P. Simon, M. Lotze, J.C. Yang, C.A. Seipp, et al. 1988. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N. Engl. J. Med. 319:1676-1680.
3. Aebersold, P., C Hyatt, S. Johnson, K. Hines, L. Korcak, M. Sanders, M. Lotze, S. Topahan, J. Yang, and S.A. Rosenberg. 1991. Lysis of autologous melanoma cells by tumor infiltrating lymphocytes: association with clinical response. J. Natl. Cancer Inst. 83:932-937.
4. Yewdell, J.W., and J.R. Bennink. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T-lymphocytes. Adv. Immunol. 52:1-123.
5. Townsend, A., and J. Trowsdale. 1993. The transporters associated with anogen presentation. Semin. Cell Biol. 4:53-61.
6. Slingluff, C.L., Jr., D.F. Hunt, and V.H. Englehard. 1994. Direct analysis of tumor-associated peptide antigens. Curr. Opin. Immunol. 6:733-740.
7. Pardoll, D.M. 1994. Tumour antigens. A new look for the 1990s. Nature (Lond.). 369:357.
8. Boon, T. 1992. Toward a genetic analysis of tumor rejection antigens. Adv. Cancer Res. 58:177-210.
9. Inaba, K., J.P. Metlay, M.T. Crowley, M. Witmer-Pack, and R.M. Steinman. 1990. Dendritic cells as antigen presenting cells in vivo. Int. Rev. Immunol. 6:197-206.
10. Steinman, R.M., M. Witmer-Pack, and K. Inaba. 1993. Dendritic cells: antigen presentation, accessory function and clinical relevance. Adv. Exp. Med. Biol. 329:1-9.
11. Inaba, K., N. Romani, and R.M. Steinman. 1989. An antigen-independent contact mechanism as an early step in T cell-proliferative responses to dendritic cells. J. Exp. Med. 170:527-542.
12. Chen, L., P.S. Linsley, and K.E. Hellström. 1993. Costimulation of T cells for tumor immunity. Immunol. Today. 14:483-486.
13. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109-1118.
14. Romani, N., S Gruner, D. Brand, E. Kampgen, A. Lenz, B. Trockenbacher, G. Konwalinka, P.O. Fritsch, R.M. Steinman, and G. Schuler. 1994. Proliferating dendritic cell progenitors in human blood. J. Exp. Med. 180:83-93.
15. Zorina, T., J.I. Mayordomo, S. Watkins, M. Lotze, A.B. DeLeo, and S.T. Ildstad. 1994. Culture of dendritic cells from murine bone marrow supplemented with GM-CSF and TNF-alpha. J. Immunother. 16:247 (Abstr.).
16. Inaba, K., R.M. Steinman, M.W. Pack, H. Aya, M. Inaba, T. Sudo, S. Wolpe, and G. Schuler. 1992. Identification of proliferating dendritic cell precursors in mouse blood. J. Exp. Med. 175:1157-1167.
17. Inaba, K., M. Inaba, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R.M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
18. Bastin, J., J. Rothbard, J. Davey, I. Jones, and A. Townsend. 1987. Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes. J. Exp. Med. 165:1508-1523.
19. + cytotoxic T lymphocytes by dendritic cells. J. Exp. Med. 166:182-194.
20. Macatonia, S.E., P.M. Taylor, S.C. Knight, and B.A. Askonas. 1989. Primary stimulation by dendritic cells induces antiviral proliferative and cytotoxic T cell responses in vitro. J. Exp. Med. 169:1255-1264.
21. Inaba, K., J.P. Metlay, M.T. Crowley, and R.M. Steinman. 1990. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ. J. Exp. Med. 172:631-640.
22. Townsend, A., T. Elliot, V. Cerundolo, L. Foster, B. Barber, and A. Tse. 1990. Assembly of MHC class I molecules analyzed in vitro. Cell. 62:285-295.
23. Porgador, A., and E. Gilboa. 1995. Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes. J. Exp. Med. 182:255-260.
24. Moore, M.W., F.R. Carbone, and M.J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell. 54:777-785.
25. Falo, L.D., Jr., M. Kovacsovics-Bankowski, K. Thompson, and K.L. Rock. 1995. Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity. Nature Med. 1:649-653.
26. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, and H.G. Rammensee. 1991 Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature (Lond.). 351:290-296.
27. Rock, K.L., L. Rothstein, and S. Gamble. 1990. Generation of class I MHC-restricted T-T hybridomas. J. Immunol. 145:804-811.
28. Rock, K L., C Fleischacker, and S. Gamble. 1993. Peptide-priming of cytolytic T cell immunity in vivo using β2-microglobulin as an adjuvant. J. Immunol. 150:1244-1251.
29. Benjamin, R.J., J.A. Madrigal, and P. Parham. 1991. Peptide binding to empty HLA-B27 molecules of viable human cells. Nature (Lond.). 351:74-77.
30. Auchincloss, H.J., R.R. Ghobrial, P.S. Russell, and H.J. Winn. 1988. Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo. Transplantation. 45:1118-1123.
31. Grabbe, S., S. Beissert, T. Schwarz, and R.D. Granstein. 1995. Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? Immunol. Today. 16:117-120.
32. Tazi, A., F. Bouchonnet, M. Grandsaigne, L. Boumsell, A.J. Hance, and P. Soler. 1993. Evidence that granulocyte macraphage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers J. Clin. Invest. 91:566-576.
33. Becker, Y. 1993. Dendritic cell activity against primary tumors: an overview. In Vivo. 7:187-191.
34. Azizi, E., C. Bucana, L. Goldberg, and M.L. Kripke. 1987. Perturbation of epidermal Langerhans cells in basal cell carcinomas. Am. J. Dermatopathol. 9:465-473.
35. Murphy, G.F., A. Radu, M. Kaminer, and D. Berd. 1993. Autologous melanoma vaccine induces inflammatory responses in melanoma metastases: relevance to immunologic regression and immunotherapy. J. Invest. Dermatol. 100:335S-341S.
36. Tsujitani, S., Y. Kakeji, A. Watanabe, S. Kohnoe, Y. Maehara, and K. Sugimachi. 1990. Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer. Cancer. 66:2012-2016.
37. Grabbe, S., S. Bruvers, R.L. Gallo, T.L. Knisely, R. Nazareno, and R.D. Granstein. 1991. Tumor antigen presentation by murine epidermal cells. J. Immunol. 146:3656-3661.
38. Cohen, P.J., P.A. Cohen, S.A. Rosenberg, S.I. Katz, and J.J. Mule. 1994. Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells. Eur. Immunol. 24:315-319.
39. Flamand, V., T. Somasse, K. Thielemans, C. Demaner, M. Bakkus, H. Bazin, F. Tielemans, O. Leo, J. Urbain, and M. Moser. 1994. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo. Eur. J. Immunol. 24:605-610.
40. + T cell activity. J. Immunol. 148:648-655.
41. Shimizu, J., T. Suda, T. Yoshioka, A. Kosugi, H. Fujiwara, and T. Hamaoka. 1989. Induction of tumor-specific in vivo protective immunity by immunization with tumor antigen-pulsed antigen-presenting cells. J. Immunol. 142:1053-1059.
42. Falo, L.D., Jr., L.J. Colarusso, B. Benacerraf, and K.L. Rock. 1992. Serum proteases alter the antigeniciry of peptides presented by class I major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA. 89:8347-8350.
43. Mayordomo, J.I., T. Zorina, W.J. Storkus, L. Zitvogel, C. Celluzzi, L.D. Falo, C.J. Melief, S.T. Ilstad, W. Martin Kast, A.B. DeLeo, and M.T. Lotze. 1995. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1:1297-1302.
44. Mayordomo, J.I., L. Zitvogel, T. Tjandrawan, M.T. Lotze, and W.J. Storkus. 1995. Dendritic cells presenting tumor peptide epitopes stimulate effective anti-tumor CTL in vitro and in vivo Proc. Intl. Assoc. Immunol. In press